drugset
drugset / Trial / NCT03907267

Taurine in Peripartum Cardiomyopathy

NCT03907267 ↗

Phase 2/3 Completed 40 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Taurine as an adjunct for early left ventricular recovery in peripartum cardiomyopathy

Timeline

Start
2015-01-01
Primary completion
2019-12-01
Completion
2020-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Taurine Other / unclassified — —

Indications

peripartum cardiomyopathy